Cynthia Clayton

Cynthia Clayton is an accomplished leader in the field of communications and investor relations, serving as Founder and CEO of Clayton Bio Communications since March 2025, and as Head of Communications at Grove Biopharma, Inc. since the same date. With extensive experience at Third Rock Ventures since October 2015, Cynthia has held various roles including Head of Communications and Investor Relations, as well as Vice President, Communications & Investor Relations. Prior experience includes significant positions at Alnylam Pharmaceuticals, Synta Pharmaceuticals, and Millennium Pharmaceuticals, where Cynthia honed expertise in corporate communications and investor relations. Academic credentials include a degree from the University of Hartford.